Neoplasia/BPH

	Primary healthcare utilisation and associated factors among post-treatment prostate cancer survivors in Tanzania: a cross-sectional study. Ecancermedicalscience Nakey RR, Kwesigabo GP, Shabani MC, Ndibalema YK, Temba AJ. PMID: 42437066 [PubMed]
	An AI-powered diagnostic system for grading and invasion of non-muscle-invasive bladder cancer via TURBT specimens: A multicenter study. iScience Zhang X, Wang H, Zhou H, Xiao D, Xiong H, Cheng J, He Y, Feng Q, Yang J. PMID: 42436972 [PubMed]
	Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances. Transl Androl Urol Gabriel PE, Ingles JC, Zhu A, Horowitz A, Sfakianos JP, Xylinas E. PMID: 42436788 [PubMed]
	Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort study. Transl Androl Urol Wang B, Xia D, Pan Y, Hu J, Liu H, Zhang X, Chen D, Huang H, Chen G, Fan J, Zhang H, Wu H, Li Z, Zhao G, Wang Q, Li L, Ye M, Yang G, Liu Y, Lin J, Gu Y, Liu F, Chen Z, Luo J, Wang L, Ying Z, He T, Lin C, Zhang X, Niu S. PMID: 42436774 [PubMed]
	A prediction model for targeted drug resistance in renal cell carcinoma based on plasma proteomics analysis. Transl Androl Urol Gan X, Yan R, Yang B, Wang J, Guo J, Wang X, Hu X, Wang L, Liu B. PMID: 42436772 [PubMed]
	A contrast-enhanced ultrasound-based nomogram for preoperative prediction of pseudocapsule status in localized clear cell renal cell carcinoma: a retrospective study. Transl Androl Urol Ma J, Wang ZF, Li F, Chen J, Wu R. PMID: 42436764 [PubMed]
	Multimodal deep learning for predicting WHO/ISUP grading in renal tumors on CT using a self-attention-based model: variable Vision Transformer (vViT). Eur J Radiol Open Usuzaki T, Matsuno E, Shizukuishi T, Inamori R, Zeng Y, Zhang X, Oguro S, Homma N, Takase K. PMID: 42436714 [PubMed]
	Substaging and Stratified Treatment of T1 Bladder Cancer - a Nationwide Register-Based Study. Eur Urol Open Sci Nielsen NK, Hjort PB, Hansen EB, Graugaard-Jensen C, Jakobsen JK, Kingo PS, Jensen JB. PMID: 42436677 [PubMed]
	Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysis. Urol Oncol Yajima S, Yoshida S, Imasato N, Chen W, Fukushima H, Tanaka H, Masuda H, Fujii Y. PMID: 42436099 [PubMed - as supplied by publisher]
	Re: David-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Shin YS, Kim JH. PMID: 42436089 [PubMed - as supplied by publisher]
	"Cumulative incidence of toxicity between 2 and 5 years following SBRT to the prostate and pelvis nodes in patients with high-risk prostate cancer ". Pract Radiat Oncol Martinez C, Cury F, Duclos M, Tsui JMG, Joseph A, Patrocinio H, Souhami L, Faria S. PMID: 42435987 [PubMed - as supplied by publisher]
	Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE. Radiother Oncol Massachi J, Jiang T, Neilsen BK, Wilhalme H, Ruan D, Casado M, Chong N, Zello L, Lamb JM, Ma TM, Valle LF, Cao M, Steinberg ML, Kishan AU. PMID: 42435817 [PubMed - as supplied by publisher]
	Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol Ito A, Arai Y, Kakehi Y, Yokoyama M, Sasaki K, Uemura M, Takahashi A, Nishimura K, Kawahara T, Masuda H, Yoshimura K, Kobayashi T, Eto M, Igawa T, Nishiyama N, Mochizuki T, Yokomizo A, Miyake M, Ichikawa T, Hashine K, Sato T, Sugimoto M, Nishiyama H, Kitamura H, Urologic Oncology Study Group of the Japan Clinical Oncology Group. PMID: 42435772 [PubMed - as supplied by publisher]
	De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When? Clin Genitourin Cancer Moinard-Butot F, Nannini S, Gravis G, Pautas M, Pignot G, Barthélémy P. PMID: 42435529 [PubMed - as supplied by publisher]
	Relationship Values and Committed Actions Among Couples Coping with Prostate Cancer: A Qualitative Study. Support Care Cancer Ma H, Yang Y, Cariola L, Gillanders D. PMID: 42435221 [PubMed - indexed for MEDLINE]
	(68)Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data. Eur J Nucl Med Mol Imaging Leithner D, Michaud L, Zheng J, Mauguen A, Cheng M, Bedmutha A, Mayerhoefer ME, A Razmaria A, Fine SW, Morris MJ, Imber BS, Zelefsky MJ, Yeh R, Schöder H. PMID: 42435202 [PubMed - as supplied by publisher]
	Metabolic Reprogramming in the Bladder Cancer Microenvironment: Bridging Fundamental Research and Therapeutic Avenues for Cancer-Associated Fibroblasts. Adv Exp Med Biol Silva A, Baltazar F, Afonso J. PMID: 42435169 [PubMed - indexed for MEDLINE]
	Frailty burden and symptomatic BPH/LUTS in aging men: evidence from two nationally representative population-based studies. World J Urol Wu G, Wang J, Shi J, Liu Y, Zheng J, Jiang X, Wang J, Pan L, Tao L. PMID: 42435056 [PubMed - indexed for MEDLINE]
	Tumor enucleation versus conventional partial nephrectomy for localized renal tumors: a systematic review and meta-analysis of functional, perioperative, and margin outcomes. Front Oncol Jiang S, Liu J, Sun L, Zhu Y, Fan Z, Li S, Zhou F. PMID: 42434757 [PubMed]
	From intracellular processing to renal phenotypes: a mechanism-informed framework for interpreting kidney injury and electrolyte patterns with antibody-drug conjugates in solid tumors. Front Pharmacol Jiang Y, Xu J, Wang Z, Zhang S. PMID: 42434135 [PubMed]

Articles 1 - 20 / 189646

Page 1 of 9483



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy